Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Caterina Bissantz | Researchclopedia

Back to researchers

Caterina Bissantz

Roche (Switzerland)

61

Works

4,431

Citations

23

h-index

35

i10-index

Research Topics

Receptor Mechanisms and Signaling Neuropeptides and Animal Physiology Antibiotic Resistance in Bacteria

Affiliations

Roche (Switzerland)2003–2025

Centre National de la Recherche Scientifique1998–2004

Purdue University West Lafayette2012–2012

American Pharmacists Association1998–2004

ETH Zurich2000–2002

Top Works

A Medicinal Chemist’s Guide to Molecular Interactions

Caterina Bissantz,Bernd Kuhn,et al.

20101,649 citations

Antibiotics Pharmacokinetics and Efficacy

Chemical Synthesis and Analysis

Protein-Based Virtual Screening of Chemical Databases. 1. Evaluation of Different Docking/Scoring Combinations

Caterina Bissantz,Gerd Folkers,et al.

2000734 citations

Protein‐based virtual screening of chemical databases. II. Are homology models of g‐protein coupled receptors suitable targets?

Caterina Bissantz,Philippe Bernard,et al.

2002296 citations

A novel antibiotic class targeting the lipopolysaccharide transporter

Claudia Zampaloni,Patrizio Mattei,et al.

2024277 citations

Probing the Cysteine-34 Position of Endogenous Serum Albumin with Thiol-Binding Doxorubicin Derivatives. Improved Efficacy of an Acid-Sensitive Doxorubicin Derivative with Specific Albumin-Binding Properties Compared to That of the Parent Compound

Felix Kratz,André Warnecke,et al.

2002271 citations

A Real-World Perspective on Molecular Design

Bernd Kuhn,Wolfgang Guba,et al.

2016120 citations

High-Throughput Modeling of Human G-Protein Coupled Receptors: Amino Acid Sequence Alignment, Three-Dimensional Model Building, and Receptor Library Screening

Caterina Bissantz,Antoine Logean,et al.

200486 citations

Can we discover pharmacological promiscuity early in the drug discovery process?

Jens‐Uwe Peters,Jérôme Hert,et al.

201283 citations

Safety screening in early drug discovery: An optimized assay panel

Stefanie Bendels,Caterina Bissantz,et al.

201982 citations